Global Liver Failure Therapeutics Market Size, Status and Forecast 2020-2026

Global Liver Failure Therapeutics Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Liver Failure Therapeutics Revenue
1.4 Market Analysis by Type
1.4.1 Global Liver Failure Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Ornithine Phenylacetate
1.4.3 MTL-CEBPA
1.4.4 F-573
1.4.5 BL-1220
1.4.6 PP-100
1.4.7 Others
1.5 Market by Application
1.5.1 Global Liver Failure Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Liver Failure Therapeutics Market Perspective (2015-2026)
2.2 Liver Failure Therapeutics Growth Trends by Regions
2.2.1 Liver Failure Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Liver Failure Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Liver Failure Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Liver Failure Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Liver Failure Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Liver Failure Therapeutics Players by Market Size
3.1.1 Global Top Liver Failure Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Liver Failure Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Liver Failure Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Liver Failure Therapeutics Market Concentration Ratio
3.2.1 Global Liver Failure Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Liver Failure Therapeutics Revenue in 2019
3.3 Liver Failure Therapeutics Key Players Head office and Area Served
3.4 Key Players Liver Failure Therapeutics Product Solution and Service
3.5 Date of Enter into Liver Failure Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Liver Failure Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Liver Failure Therapeutics Forecasted Market Size by Type (2021-2026)
5 Liver Failure Therapeutics Breakdown Data by Application (2015-2026)
5.1 Global Liver Failure Therapeutics Market Size by Application (2015-2020)
5.2 Global Liver Failure Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Liver Failure Therapeutics Market Size (2015-2020)
6.2 Liver Failure Therapeutics Key Players in North America (2019-2020)
6.3 North America Liver Failure Therapeutics Market Size by Type (2015-2020)
6.4 North America Liver Failure Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Liver Failure Therapeutics Market Size (2015-2020)
7.2 Liver Failure Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Liver Failure Therapeutics Market Size by Type (2015-2020)
7.4 Europe Liver Failure Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Liver Failure Therapeutics Market Size (2015-2020)
8.2 Liver Failure Therapeutics Key Players in China (2019-2020)
8.3 China Liver Failure Therapeutics Market Size by Type (2015-2020)
8.4 China Liver Failure Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Liver Failure Therapeutics Market Size (2015-2020)
9.2 Liver Failure Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Liver Failure Therapeutics Market Size by Type (2015-2020)
9.4 Japan Liver Failure Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Liver Failure Therapeutics Market Size (2015-2020)
10.2 Liver Failure Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Liver Failure Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Liver Failure Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Liver Failure Therapeutics Market Size (2015-2020)
11.2 Liver Failure Therapeutics Key Players in India (2019-2020)
11.3 India Liver Failure Therapeutics Market Size by Type (2015-2020)
11.4 India Liver Failure Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Liver Failure Therapeutics Market Size (2015-2020)
12.2 Liver Failure Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Liver Failure Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Liver Failure Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Alfact Innovation
13.1.1 Alfact Innovation Company Details
13.1.2 Alfact Innovation Business Overview and Its Total Revenue
13.1.3 Alfact Innovation Liver Failure Therapeutics Introduction
13.1.4 Alfact Innovation Revenue in Liver Failure Therapeutics Business (2015-2020))
13.1.5 Alfact Innovation Recent Development
13.2 BioLineRx Ltd
13.2.1 BioLineRx Ltd Company Details
13.2.2 BioLineRx Ltd Business Overview and Its Total Revenue
13.2.3 BioLineRx Ltd Liver Failure Therapeutics Introduction
13.2.4 BioLineRx Ltd Revenue in Liver Failure Therapeutics Business (2015-2020)
13.2.5 BioLineRx Ltd Recent Development
13.3 Cell2B Advanced Therapeutics SA
13.3.1 Cell2B Advanced Therapeutics SA Company Details
13.3.2 Cell2B Advanced Therapeutics SA Business Overview and Its Total Revenue
13.3.3 Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Introduction
13.3.4 Cell2B Advanced Therapeutics SA Revenue in Liver Failure Therapeutics Business (2015-2020)
13.3.5 Cell2B Advanced Therapeutics SA Recent Development
13.4 Conatus Pharmaceuticals Inc
13.4.1 Conatus Pharmaceuticals Inc Company Details
13.4.2 Conatus Pharmaceuticals Inc Business Overview and Its Total Revenue
13.4.3 Conatus Pharmaceuticals Inc Liver Failure Therapeutics Introduction
13.4.4 Conatus Pharmaceuticals Inc Revenue in Liver Failure Therapeutics Business (2015-2020)
13.4.5 Conatus Pharmaceuticals Inc Recent Development
13.5 Immune Pharmaceuticals Inc
13.5.1 Immune Pharmaceuticals Inc Company Details
13.5.2 Immune Pharmaceuticals Inc Business Overview and Its Total Revenue
13.5.3 Immune Pharmaceuticals Inc Liver Failure Therapeutics Introduction
13.5.4 Immune Pharmaceuticals Inc Revenue in Liver Failure Therapeutics Business (2015-2020)
13.5.5 Immune Pharmaceuticals Inc Recent Development
13.6 Mina Therapeutics Ltd
13.6.1 Mina Therapeutics Ltd Company Details
13.6.2 Mina Therapeutics Ltd Business Overview and Its Total Revenue
13.6.3 Mina Therapeutics Ltd Liver Failure Therapeutics Introduction
13.6.4 Mina Therapeutics Ltd Revenue in Liver Failure Therapeutics Business (2015-2020)
13.6.5 Mina Therapeutics Ltd Recent Development
13.7 Mylan NV
13.7.1 Mylan NV Company Details
13.7.2 Mylan NV Business Overview and Its Total Revenue
13.7.3 Mylan NV Liver Failure Therapeutics Introduction
13.7.4 Mylan NV Revenue in Liver Failure Therapeutics Business (2015-2020)
13.7.5 Mylan NV Recent Development
13.8 Ocera Therapeutics Inc
13.8.1 Ocera Therapeutics Inc Company Details
13.8.2 Ocera Therapeutics Inc Business Overview and Its Total Revenue
13.8.3 Ocera Therapeutics Inc Liver Failure Therapeutics Introduction
13.8.4 Ocera Therapeutics Inc Revenue in Liver Failure Therapeutics Business (2015-2020)
13.8.5 Ocera Therapeutics Inc Recent Development
13.9 PledPharma AB
13.9.1 PledPharma AB Company Details
13.9.2 PledPharma AB Business Overview and Its Total Revenue
13.9.3 PledPharma AB Liver Failure Therapeutics Introduction
13.9.4 PledPharma AB Revenue in Liver Failure Therapeutics Business (2015-2020)
13.9.5 PledPharma AB Recent Development
13.10 Promethera Biosciences SA
13.10.1 Promethera Biosciences SA Company Details
13.10.2 Promethera Biosciences SA Business Overview and Its Total Revenue
13.10.3 Promethera Biosciences SA Liver Failure Therapeutics Introduction
13.10.4 Promethera Biosciences SA Revenue in Liver Failure Therapeutics Business (2015-2020)
13.10.5 Promethera Biosciences SA Recent Development
13.11 Silence Therapeutics Plc
10.11.1 Silence Therapeutics Plc Company Details
10.11.2 Silence Therapeutics Plc Business Overview and Its Total Revenue
10.11.3 Silence Therapeutics Plc Liver Failure Therapeutics Introduction
10.11.4 Silence Therapeutics Plc Revenue in Liver Failure Therapeutics Business (2015-2020)
10.11.5 Silence Therapeutics Plc Recent Development
13.12 Unicyte AG
10.12.1 Unicyte AG Company Details
10.12.2 Unicyte AG Business Overview and Its Total Revenue
10.12.3 Unicyte AG Liver Failure Therapeutics Introduction
10.12.4 Unicyte AG Revenue in Liver Failure Therapeutics Business (2015-2020)
10.12.5 Unicyte AG Recent Development
13.13 Ventria Bioscience
10.13.1 Ventria Bioscience Company Details
10.13.2 Ventria Bioscience Business Overview and Its Total Revenue
10.13.3 Ventria Bioscience Liver Failure Therapeutics Introduction
10.13.4 Ventria Bioscience Revenue in Liver Failure Therapeutics Business (2015-2020)
10.13.5 Ventria Bioscience Recent Development
13.14 Vital Therapies Inc
10.14.1 Vital Therapies Inc Company Details
10.14.2 Vital Therapies Inc Business Overview and Its Total Revenue
10.14.3 Vital Therapies Inc Liver Failure Therapeutics Introduction
10.14.4 Vital Therapies Inc Revenue in Liver Failure Therapeutics Business (2015-2020)
10.14.5 Vital Therapies Inc Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Liver Failure Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Liver Failure Therapeutics Revenue
Table 3. Ranking of Global Top Liver Failure Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Liver Failure Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Ornithine Phenylacetate
Table 6. Key Players of MTL-CEBPA
Table 7. Key Players of F-573
Table 8. Key Players of BL-1220
Table 9. Key Players of PP-100
Table 10. Key Players of Others
Table 11. Global Liver Failure Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Liver Failure Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Liver Failure Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Liver Failure Therapeutics Market Share by Regions (2015-2020)
Table 15. Global Liver Failure Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Liver Failure Therapeutics Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Liver Failure Therapeutics Market Growth Strategy
Table 21. Main Points Interviewed from Key Liver Failure Therapeutics Players
Table 22. Global Liver Failure Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 23. Global Liver Failure Therapeutics Market Share by Players (2015-2020)
Table 24. Global Top Liver Failure Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liver Failure Therapeutics as of 2019)
Table 25. Global Liver Failure Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Liver Failure Therapeutics Product Solution and Service
Table 28. Date of Enter into Liver Failure Therapeutics Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Liver Failure Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 31. Global Liver Failure Therapeutics Market Size Share by Type (2015-2020)
Table 32. Global Liver Failure Therapeutics Revenue Market Share by Type (2021-2026)
Table 33. Global Liver Failure Therapeutics Market Size Share by Application (2015-2020)
Table 34. Global Liver Failure Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 35. Global Liver Failure Therapeutics Market Size Share by Application (2021-2026)
Table 36. North America Key Players Liver Failure Therapeutics Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Liver Failure Therapeutics Market Share (2019-2020)
Table 38. North America Liver Failure Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 39. North America Liver Failure Therapeutics Market Share by Type (2015-2020)
Table 40. North America Liver Failure Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 41. North America Liver Failure Therapeutics Market Share by Application (2015-2020)
Table 42. Europe Key Players Liver Failure Therapeutics Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Liver Failure Therapeutics Market Share (2019-2020)
Table 44. Europe Liver Failure Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Liver Failure Therapeutics Market Share by Type (2015-2020)
Table 46. Europe Liver Failure Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Liver Failure Therapeutics Market Share by Application (2015-2020)
Table 48. China Key Players Liver Failure Therapeutics Revenue (2019-2020) (Million US$)
Table 49. China Key Players Liver Failure Therapeutics Market Share (2019-2020)
Table 50. China Liver Failure Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 51. China Liver Failure Therapeutics Market Share by Type (2015-2020)
Table 52. China Liver Failure Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 53. China Liver Failure Therapeutics Market Share by Application (2015-2020)
Table 54. Japan Key Players Liver Failure Therapeutics Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Liver Failure Therapeutics Market Share (2019-2020)
Table 56. Japan Liver Failure Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Liver Failure Therapeutics Market Share by Type (2015-2020)
Table 58. Japan Liver Failure Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Liver Failure Therapeutics Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Liver Failure Therapeutics Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Liver Failure Therapeutics Market Share (2019-2020)
Table 62. Southeast Asia Liver Failure Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Liver Failure Therapeutics Market Share by Type (2015-2020)
Table 64. Southeast Asia Liver Failure Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Liver Failure Therapeutics Market Share by Application (2015-2020)
Table 66. India Key Players Liver Failure Therapeutics Revenue (2019-2020) (Million US$)
Table 67. India Key Players Liver Failure Therapeutics Market Share (2019-2020)
Table 68. India Liver Failure Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 69. India Liver Failure Therapeutics Market Share by Type (2015-2020)
Table 70. India Liver Failure Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 71. India Liver Failure Therapeutics Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Liver Failure Therapeutics Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Liver Failure Therapeutics Market Share (2019-2020)
Table 74. Central & South America Liver Failure Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Liver Failure Therapeutics Market Share by Type (2015-2020)
Table 76. Central & South America Liver Failure Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Liver Failure Therapeutics Market Share by Application (2015-2020)
Table 78. Alfact Innovation Company Details
Table 79. Alfact Innovation Business Overview
Table 80. Alfact Innovation Product
Table 81. Alfact Innovation Revenue in Liver Failure Therapeutics Business (2015-2020) (Million US$)
Table 82. Alfact Innovation Recent Development
Table 83. BioLineRx Ltd Company Details
Table 84. BioLineRx Ltd Business Overview
Table 85. BioLineRx Ltd Product
Table 86. BioLineRx Ltd Revenue in Liver Failure Therapeutics Business (2015-2020) (Million US$)
Table 87. BioLineRx Ltd Recent Development
Table 88. Cell2B Advanced Therapeutics SA Company Details
Table 89. Cell2B Advanced Therapeutics SA Business Overview
Table 90. Cell2B Advanced Therapeutics SA Product
Table 91. Cell2B Advanced Therapeutics SA Revenue in Liver Failure Therapeutics Business (2015-2020) (Million US$)
Table 92. Cell2B Advanced Therapeutics SA Recent Development
Table 93. Conatus Pharmaceuticals Inc Company Details
Table 94. Conatus Pharmaceuticals Inc Business Overview
Table 95. Conatus Pharmaceuticals Inc Product
Table 96. Conatus Pharmaceuticals Inc Revenue in Liver Failure Therapeutics Business (2015-2020) (Million US$)
Table 97. Conatus Pharmaceuticals Inc Recent Development
Table 98. Immune Pharmaceuticals Inc Company Details
Table 99. Immune Pharmaceuticals Inc Business Overview
Table 100. Immune Pharmaceuticals Inc Product
Table 101. Immune Pharmaceuticals Inc Revenue in Liver Failure Therapeutics Business (2015-2020) (Million US$)
Table 102. Immune Pharmaceuticals Inc Recent Development
Table 103. Mina Therapeutics Ltd Company Details
Table 104. Mina Therapeutics Ltd Business Overview
Table 105. Mina Therapeutics Ltd Product
Table 106. Mina Therapeutics Ltd Revenue in Liver Failure Therapeutics Business (2015-2020) (Million US$)
Table 107. Mina Therapeutics Ltd Recent Development
Table 108. Mylan NV Company Details
Table 109. Mylan NV Business Overview
Table 110. Mylan NV Product
Table 111. Mylan NV Revenue in Liver Failure Therapeutics Business (2015-2020) (Million US$)
Table 112. Mylan NV Recent Development
Table 113. Ocera Therapeutics Inc Business Overview
Table 114. Ocera Therapeutics Inc Product
Table 115. Ocera Therapeutics Inc Company Details
Table 116. Ocera Therapeutics Inc Revenue in Liver Failure Therapeutics Business (2015-2020) (Million US$)
Table 117. Ocera Therapeutics Inc Recent Development
Table 118. PledPharma AB Company Details
Table 119. PledPharma AB Business Overview
Table 120. PledPharma AB Product
Table 121. PledPharma AB Revenue in Liver Failure Therapeutics Business (2015-2020) (Million US$)
Table 122. PledPharma AB Recent Development
Table 123. Promethera Biosciences SA Company Details
Table 124. Promethera Biosciences SA Business Overview
Table 125. Promethera Biosciences SA Product
Table 126. Promethera Biosciences SA Revenue in Liver Failure Therapeutics Business (2015-2020) (Million US$)
Table 127. Promethera Biosciences SA Recent Development
Table 128. Silence Therapeutics Plc Company Details
Table 129. Silence Therapeutics Plc Business Overview
Table 130. Silence Therapeutics Plc Product
Table 131. Silence Therapeutics Plc Revenue in Liver Failure Therapeutics Business (2015-2020) (Million US$)
Table 132. Silence Therapeutics Plc Recent Development
Table 133. Unicyte AG Company Details
Table 134. Unicyte AG Business Overview
Table 135. Unicyte AG Product
Table 136. Unicyte AG Revenue in Liver Failure Therapeutics Business (2015-2020) (Million US$)
Table 137. Unicyte AG Recent Development
Table 138. Ventria Bioscience Company Details
Table 139. Ventria Bioscience Business Overview
Table 140. Ventria Bioscience Product
Table 141. Ventria Bioscience Revenue in Liver Failure Therapeutics Business (2015-2020) (Million US$)
Table 142. Ventria Bioscience Recent Development
Table 143. Vital Therapies Inc Company Details
Table 144. Vital Therapies Inc Business Overview
Table 145. Vital Therapies Inc Product
Table 146. Vital Therapies Inc Revenue in Liver Failure Therapeutics Business (2015-2020) (Million US$)
Table 147. Vital Therapies Inc Recent Development
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Liver Failure Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Ornithine Phenylacetate Features
Figure 3. MTL-CEBPA Features
Figure 4. F-573 Features
Figure 5. BL-1220 Features
Figure 6. PP-100 Features
Figure 7. Others Features
Figure 8. Global Liver Failure Therapeutics Market Share by Application: 2020 VS 2026
Figure 9. Clinic Case Studies
Figure 10. Hospital Case Studies
Figure 11. Others Case Studies
Figure 12. Liver Failure Therapeutics Report Years Considered
Figure 13. Global Liver Failure Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Liver Failure Therapeutics Market Share by Regions: 2020 VS 2026
Figure 15. Global Liver Failure Therapeutics Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Liver Failure Therapeutics Market Share by Players in 2019
Figure 18. Global Top Liver Failure Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liver Failure Therapeutics as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Liver Failure Therapeutics Revenue in 2019
Figure 20. North America Liver Failure Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Liver Failure Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Liver Failure Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Liver Failure Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Liver Failure Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Liver Failure Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Liver Failure Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Alfact Innovation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Alfact Innovation Revenue Growth Rate in Liver Failure Therapeutics Business (2015-2020)
Figure 29. BioLineRx Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. BioLineRx Ltd Revenue Growth Rate in Liver Failure Therapeutics Business (2015-2020)
Figure 31. Cell2B Advanced Therapeutics SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Cell2B Advanced Therapeutics SA Revenue Growth Rate in Liver Failure Therapeutics Business (2015-2020)
Figure 33. Conatus Pharmaceuticals Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Conatus Pharmaceuticals Inc Revenue Growth Rate in Liver Failure Therapeutics Business (2015-2020)
Figure 35. Immune Pharmaceuticals Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Immune Pharmaceuticals Inc Revenue Growth Rate in Liver Failure Therapeutics Business (2015-2020)
Figure 37. Mina Therapeutics Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Mina Therapeutics Ltd Revenue Growth Rate in Liver Failure Therapeutics Business (2015-2020)
Figure 39. Mylan NV Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Mylan NV Revenue Growth Rate in Liver Failure Therapeutics Business (2015-2020)
Figure 41. Ocera Therapeutics Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Ocera Therapeutics Inc Revenue Growth Rate in Liver Failure Therapeutics Business (2015-2020)
Figure 43. PledPharma AB Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. PledPharma AB Revenue Growth Rate in Liver Failure Therapeutics Business (2015-2020)
Figure 45. Promethera Biosciences SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Promethera Biosciences SA Revenue Growth Rate in Liver Failure Therapeutics Business (2015-2020)
Figure 47. Silence Therapeutics Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Silence Therapeutics Plc Revenue Growth Rate in Liver Failure Therapeutics Business (2015-2020)
Figure 49. Unicyte AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Unicyte AG Revenue Growth Rate in Liver Failure Therapeutics Business (2015-2020)
Figure 51. Ventria Bioscience Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Ventria Bioscience Revenue Growth Rate in Liver Failure Therapeutics Business (2015-2020)
Figure 53. Vital Therapies Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Vital Therapies Inc Revenue Growth Rate in Liver Failure Therapeutics Business (2015-2020)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs